Does coenzyme Q10 supplementation improve heart failure outcomes?

Who benefits most from CoQ10? The type of heart failure matters.

The strongest evidence for CoQ10 is in patients with heart failure with reduced ejection fraction (HFrEF), where the heart's pumping ability is measurably weak. A 2024 meta-analysis of 33 randomized trials found that CoQ10 reduced all-cause mortality by 36% (risk ratio 0.64) and hospitalizations for heart failure by 50% (risk ratio 0.50) [3]. These are large, clinically meaningful reductions. Another overview of 10 meta-analyses confirmed a similar mortality reduction (about 31-42%) and a 38% drop in hospitalizations [7]. A UK health technology assessment also found a possible mortality benefit (relative risk 0.68) and concluded CoQ10 is likely cost-effective for HFrEF [4].

In contrast, a small but well-designed trial in patients with heart failure with preserved ejection fraction (HFpEF) — where the heart is stiff but pumps normally — found no benefit. After 4 months, CoQ10 did not improve diastolic function (the heart's ability to relax) or NT-proBNP levels (a marker of heart strain) compared to placebo [8]. This suggests CoQ10's benefits may be limited to HFrEF, though more research is needed in HFpEF.

What exactly does CoQ10 improve? Exercise capacity, heart function, and quality of life.

CoQ10 consistently improves functional capacity — how much you can do before getting short of breath. In a 2025 randomized trial of 120 patients, those taking CoQ10 (120 mg daily for 6 months) walked 82 meters farther in the six-minute walk test (349 vs. 267 meters) and had significantly better global longitudinal strain (a sensitive measure of heart muscle function) [1]. The meta-analysis found a more modest but still meaningful improvement of about 32 meters on the six-minute walk test [3]. A separate 2025 trial combining CoQ10 with exercise training showed a 20% improvement in walk distance and a 25% improvement in peak oxygen uptake (VO₂ peak), which reflects aerobic fitness [2].

CoQ10 also reduces markers of heart strain. The 2025 trial found NT-proBNP levels (a blood test that rises when the heart is stressed) were nearly 40% lower in the CoQ10 group compared to placebo (816 vs. 1379 pg/mL) [1]. The meta-analysis confirmed a significant drop in BNP levels [3]. Quality of life also improved: the 2025 exercise-plus-supplement trial reported a 26% better health-related quality of life score [2], and the 2025 RCT found improvements in blood pressure and functional class [1].

What dose is used, and is it safe?

The typical dose in successful trials is 100-120 mg of CoQ10 per day, often split into two doses. The 2025 RCT used 60 mg twice daily (120 mg total) [1], and the meta-analysis included trials with similar dosing [3]. CoQ10 appears very safe: the meta-analysis found no major adverse effects [3], and the UK health technology assessment reported no increase in side effects compared to placebo [4]. However, absorption varies widely between brands and formulations. Some newer formulations combine CoQ10 with piperine (from black pepper) or vitamin E to boost absorption — one preclinical study showed piperine increased CoQ10 blood levels by about 30% [5][6]. If you try CoQ10, choose a reputable brand with good bioavailability.

One important caveat: CoQ10 can interact with blood thinners like warfarin, potentially reducing their effectiveness. If you take warfarin, talk to your doctor before starting CoQ10. Also, while statins (cholesterol-lowering drugs) are thought to lower natural CoQ10 levels, the UK analysis found no evidence that CoQ10 works better in statin users — the benefit was similar regardless [4].

About These Sources

This answer is built on 8 peer-reviewed studies — published from 2021 to 2026, 5 from 2024 or later, 2 in Q1 journals, collectively cited 55 times — selected as the most relevant from 10 studies that passed quality screening, drawn from 61 papers retrieved from a database of over 500 million.

Sources used in this answer

Related research questions